...
首页> 外文期刊>OncoTargets and therapy >HIF1α/PD-L1 axis mediates hypoxia-induced cell apoptosis and tumor progression in follicular thyroid carcinoma
【24h】

HIF1α/PD-L1 axis mediates hypoxia-induced cell apoptosis and tumor progression in follicular thyroid carcinoma

机译:HIF1α/ PD-L1轴介导低氧诱导的滤泡性甲状腺癌细胞凋亡和肿瘤进展

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Hypoxia-inducible factor 1α (HIF-1α) and programmed cell death-1 protein ligand 1 (PD-L1) are implicated in the metastasis and progression processes of multiple cancers. Hypoxia selectively elevates PD-L1 expression via HIF1α activation in several solid tumors; however, the regulatory effect of HIF1α on PD-L1 in the pathogenesis of follicular thyroid cancer (FTC) remains unclear. This study aims to investigate the regulatory effect of HIF1α on PD-L1 and their potential roles in FTC pathogenesis. Methods: Spearman correlation analysis was performed to clarify the relationships between HIF1α and PD-L1 expressions and the clinicopathologic characteristics. The expressions of HIF1α and PD-L1 at mRNA and protein levels were analyzed by qRT-PCR and Western blot. Hypoxia induction and cell transfection were conducted in FTC cells. TUNEL and Annexin V staining were used to detect the cell apoptosis. FTC xenograft tumor models were generated to evaluate the roles of HIF1α and PD-L1 in vivo. Results: Here, we found that the expressions of HIF1α and PD-L1 were significantly increased in FTC tissues and were correlated with the FTC clinicopathologic features, such as the tumor size, T stage, TNM staging, and metastasis. In FTC cells, hypoxia-induced increased HIF1α and PD-L1 expression. Knockdown of HIF1α inhibits hypoxia-induced PD-L1 expression and cells apoptosis. Moreover, inhibition of HIF1α or PD-L1 significantly delays tumor growth and metastasis in vivo. Conclusion: Hypoxia could promote FTC progression by upregulating HIF1α and PD-L1, which could serve as the molecular targets for FTC treatment.
机译:背景:缺氧诱导因子1α(HIF-1α)和程序性细胞死亡1蛋白配体1(PD-L1)与多种癌症的转移和进展过程有关。缺氧通过多种实体瘤中的HIF1α激活选择性提高PD-L1表达;然而,在滤泡性甲状腺癌(FTC)的发病机理中,HIF1α对PD-L1的调控作用尚不清楚。这项研究旨在调查HIF1α对PD-L1的调控作用及其在FTC发病机理中的潜在作用。方法:进行Spearman相关分析以阐明HIF1α和PD-L1表达与临床病理特征之间的关系。通过qRT-PCR和Western blot分析HIF1α和PD-L1在mRNA和蛋白质水平的表达。在FTC细胞中进行缺氧诱导和细胞转染。 TUNEL和膜联蛋白V染色用于检测细胞凋亡。生成了FTC异种移植肿瘤模型以评估HIF1α和PD-L1在体内的作用。结果:在这里,我们发现FTC组织中HIF1α和PD-L1的表达显着增加,并且与FTC临床病理特征相关,例如肿瘤大小,T分期,TNM分期和转移。在FTC细胞中,缺氧诱导的HIF1α和PD-L1表达增加。抑制HIF1α抑制缺氧诱导的PD-L1表达和细胞凋亡。此外,HIF1α或PD-L1的抑制作用显着延迟了体内肿瘤的生长和转移。结论:缺氧可通过上调HIF1α和PD-L1促进FTC的进程,这可作为FTC治疗的分子靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号